Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 152 The United Laboratories International Holdings Limited Annual Report 2023 46. INFORMATION ABOUT THE STATEMENT OF FINANCIAL POSITION OF THE COMPANY (a) Statement of financial position of the Company 2023 2022 RMB’000 RMB’000 Non-current assets Interests in subsidiaries 2,552,000 4,260,026 Right-of-use assets 3,015 3,856 Property, plant and equipment 184 82 2,555,199 4,263,964 Current assets Other receivables and prepayments 7,723 2,831 Amounts due from subsidiaries 1,550,920 2,706,364 Derivative financial instruments – 1,841 Cash and cash equivalents 1,027,597 690,361 2,586,240 3,401,397 Current liabilities Other payables and accrued charges 8,187 10,616 Amount due to a subsidiary 196,199 228,038 Borrowings – due within one year 80,000 1,107,980 Derivative financial instrument 25,587 10,087 Lease liabilities 828 806 Tax payables 2,243 564 313,044 1,358,091 Net current assets 2,273,196 2,043,306 Total assets less current liabilities 4,828,395 6,307,270 Non-current liabilities Borrowings – due after one year – 1,095,789 Derivative financial instrument 19,191 – Lease liabilities 2,244 3,071 21,435 1,098,860 Net assets 4,806,960 5,208,410 Capital and reserves Share capital 16,965 16,965 Reserves 4,789,995 5,191,445 Total equity 4,806,960 5,208,410